Role of 0.01% Atropine in Myopia Control of High Myopic Children Of Moradabad (India)
Phase 4
- Conditions
- Health Condition 1: H538- Other visual disturbances
- Registration Number
- CTRI/2021/10/037447
- Lead Sponsor
- CL Gupta Eye Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age: 6 to 16 years
Myopia >= 5.00 D (cycloplegic refraction; spherical equivalent)
No prior or current treatment for preventing myopia progression
Exclusion Criteria
Best corrected visual acuity < 0.5 (6/12)
Refractive Myopia
Astigmatism >= 1.5 D
Amblyopia
Ocular hypertension / Glaucoma
Prior intraocular surgery
Allergy to atropine eye drops
Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome
History of cardiac or significant respiratory diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression of Myopia in Diopters (Spherical equivalent relative to baseline)Timepoint: 6 Month, 12 Month, 18 Month, 24 Month, 30 Month and 36 Month
- Secondary Outcome Measures
Name Time Method Change in axial lengthTimepoint: At 1 and 2 years